These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20849829)

  • 1. A three-dimensional organotypic assay to measure target cell killing by cytotoxic T lymphocytes.
    Weigelin B; Friedl P
    Biochem Pharmacol; 2010 Dec; 80(12):2087-91. PubMed ID: 20849829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells.
    He L; Hakimi J; Salha D; Miron I; Dunn P; Radvanyi L
    J Immunol Methods; 2005 Sep; 304(1-2):43-59. PubMed ID: 16076473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates.
    Liu L; Chahroudi A; Silvestri G; Wernett ME; Kaiser WJ; Safrit JT; Komoriya A; Altman JD; Packard BZ; Feinberg MB
    Nat Med; 2002 Feb; 8(2):185-9. PubMed ID: 11821904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells induce apoptosis via a novel mechanism in fibroblasts infected with mouse hepatitis virus.
    Nishioka WK; Welsh RM
    Nat Immun; 1993; 12(3):113-27. PubMed ID: 8392406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.
    Hermans IF; Silk JD; Yang J; Palmowski MJ; Gileadi U; McCarthy C; Salio M; Ronchese F; Cerundolo V
    J Immunol Methods; 2004 Feb; 285(1):25-40. PubMed ID: 14871532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The exocytosis of lytic granules is impaired in Vti1b- or Vamp8-deficient CTL leading to a reduced cytotoxic activity following antigen-specific activation.
    Dressel R; Elsner L; Novota P; Kanwar N; Fischer von Mollard G
    J Immunol; 2010 Jul; 185(2):1005-14. PubMed ID: 20543108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro.
    Ehl S; Klenerman P; Aichele P; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1997 Dec; 27(12):3404-13. PubMed ID: 9464829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine A and peripheral tolerance. Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes.
    Hiruma K; Gress RE
    J Immunol; 1992 Sep; 149(5):1539-47. PubMed ID: 1387142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
    Yang HY; Dundon PL; Nahill SR; Welsh RM
    J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FL-CTL assay: fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells.
    Chen K; Chen L; Zhao P; Marrero L; Keoshkerian E; Ramsay A; Cui Y
    J Immunol Methods; 2005 May; 300(1-2):100-14. PubMed ID: 15899496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes.
    Jennings SR
    J Immunol; 1985 Nov; 135(5):3530-6. PubMed ID: 2413124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity.
    van Baalen CA; Kwa D; Verschuren EJ; Reedijk ML; Boon AC; de Mutsert G; Rimmelzwaan GF; Osterhaus AD; Gruters RA
    J Infect Dis; 2005 Oct; 192(7):1183-90. PubMed ID: 16136460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Ca2+ in activation of mature cytotoxic T lymphocytes for lysis.
    Ostergaard H; Clark WR
    J Immunol; 1987 Dec; 139(11):3573-9. PubMed ID: 3500223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
    J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.